Shutter LA et al. |
Cortical blindness and white matter lesions in a patient receiving FK506 after liver transplantation. |
1993 |
Neurology |
pmid:7694189
|
Kawauchi M et al. |
Prolonged survival of orthotopically transplanted heart xenograft in infant baboons. |
1993 |
J. Thorac. Cardiovasc. Surg. |
pmid:7693999
|
Tzakis AG et al. |
Intestinal transplantation in children under FK 506 immunosuppression. |
1993 |
J. Pediatr. Surg. |
pmid:7693907
|
Thomson AW et al. |
Comparative effects of rapamycin, FK 506 and cyclosporine on antibody production, lymphocyte populations and immunoglobulin isotype switching in the rat. |
1993 |
Immunopharmacol Immunotoxicol |
pmid:7693791
|
Smith DF et al. |
FKBP54, a novel FK506-binding protein in avian progesterone receptor complexes and HeLa extracts. |
1993 |
J. Biol. Chem. |
pmid:7693698
|
Schwaninger M et al. |
Inhibition of cAMP-responsive element-mediated gene transcription by cyclosporin A and FK506 after membrane depolarization. |
1993 |
J. Biol. Chem. |
pmid:7693684
|
Timerman AP et al. |
The calcium release channel of sarcoplasmic reticulum is modulated by FK-506-binding protein. Dissociation and reconstitution of FKBP-12 to the calcium release channel of skeletal muscle sarcoplasmic reticulum. |
1993 |
J. Biol. Chem. |
pmid:7693682
|
Keicho N et al. |
Antilymphocytic activity of erythromycin distinct from that of FK506 or cyclosporin A. |
1993 |
J. Antibiot. |
pmid:7693639
|
Shafiee A et al. |
Enzymatic synthesis and immunosuppressive activity of novel desmethylated immunomycins (ascomycins). |
1993 |
J. Antibiot. |
pmid:7693638
|
Schmitt J et al. |
Cloning and expression of a mouse cDNA encoding p59, an immunophilin that associates with the glucocorticoid receptor. |
1993 |
Gene |
pmid:7693550
|
Higa A et al. |
Attenuation of epithelial injury in acute experimental colitis by immunomodulators. |
1993 |
Eur. J. Pharmacol. |
pmid:7693488
|
Nakamura T et al. |
Protein phosphatase type 2B (calcineurin)-mediated, FK506-sensitive regulation of intracellular ions in yeast is an important determinant for adaptation to high salt stress conditions. |
1993 |
EMBO J. |
pmid:7693452
|
Wallemacq PE and Reding R |
FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects. |
1993 |
Clin. Chem. |
pmid:7693372
|
David M et al. |
[Changes in cervix cytology in women with liver transplants treated with immunosuppressive therapy]. |
1993 |
Zentralbl Gynakol |
pmid:7692689
|
Liu J |
FK506 and ciclosporin: molecular probes for studying intracellular signal transduction. |
1993 |
Trends Pharmacol. Sci. |
pmid:7692652
|
Akita K and Mandel TE |
Effect of FK 506 and anti-CD4 monoclonal antibody treatment on xenografts of organ-cultured fetal pig pancreas and host lymphoid populations. |
1993 |
Transplant. Proc. |
pmid:7692650
|
Wang SC et al. |
A dual mechanism of immunosuppression by FK-506. Differential suppression of IL-4 and IL-10 levels in T helper 2 cells. |
1993 |
Transplantation |
pmid:7692640
|
Tabasco-Minguillan J et al. |
Insulin requirements after liver transplantation and FK-506 immunosuppression. |
1993 |
Transplantation |
pmid:7692637
|
McDiarmid SV et al. |
A comparison of renal function in cyclosporine- and FK-506-treated patients after primary orthotopic liver transplantation. |
1993 |
Transplantation |
pmid:7692636
|
Storb R et al. |
FK-506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated dog leukocyte antigen-nonidentical donors. |
1993 |
Transplantation |
pmid:7692635
|
Roberts JP et al. |
Reversal of chronic rejection after treatment failure with FK506 and RS61443. |
1993 |
Transplantation |
pmid:7692634
|
Hill CC et al. |
Penile prosthesis surgery in the immunosuppressed patient. |
1993 |
Transplantation |
pmid:7692633
|
Wakugami T et al. |
Effect of FK506 on the development of diabetes in BB rats in comparison with that of cyclosporin. |
1993 |
Tohoku J. Exp. Med. |
pmid:7692621
|
Izumi S and Okuhara M |
[FK506 and kifunensine, new immunomodulators of microbial origin]. |
1993 |
Tanpakushitsu Kakusan Koso |
pmid:7692469
|
Lhoëst G et al. |
Isolation and identification by FAB mass spectrometry and NMR spectroscopy of a demethylated metabolite of FK506 from erythromycin-induced rabbit liver microsomes. |
1993 |
Pharm Acta Helv |
pmid:7692454
|
Nagata K et al. |
Failure of FK-506, a new immunosuppressant, to prevent cerebral vasospasm in a canine two-hemorrhage model. |
1993 |
J. Neurosurg. |
pmid:7692019
|
Schulz BS et al. |
Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro. |
1993 |
J. Immunol. |
pmid:7691948
|
Wesselborg S et al. |
Triggering via the alternative CD2 pathway induces apoptosis in activated human T lymphocytes. |
1993 |
Eur. J. Immunol. |
pmid:7691614
|
Muthukkumar S et al. |
Elevation of cytosolic calcium is sufficient to induce growth inhibition in a B cell lymphoma. |
1993 |
Eur. J. Immunol. |
pmid:7691606
|
Distant DA and Gonwa TA |
The kidney in liver transplantation. |
1993 |
J. Am. Soc. Nephrol. |
pmid:7691205
|
Mori T et al. |
FK-506: a new immunosuppressive agent, failed to reduce cerebral vasospasm after experimental subarachnoid hemorrhage. |
1993 |
J. Vet. Med. Sci. |
pmid:7691190
|
Liu J |
FK506 and cyclosporin, molecular probes for studying intracellular signal transduction. |
1993 |
Immunol. Today |
pmid:7691065
|
Wenzel-Seifert K and Seifert R |
Partial inhibition of human neutrophil activation by FK-506 at supratherapeutic concentrations. |
1993 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:7690907
|
Nakajima J |
[The immunosuppressive effects of FK506 on single lung allotransplantation in Japanese monkey (Macaca fuscata)]. |
1993 |
Nihon Kyobu Geka Gakkai Zasshi |
pmid:7690829
|
Piekoszewski W et al. |
Disposition of tacrolimus (FK 506) in rabbits. Role of red blood cell binding in hepatic clearance. |
1993 Jul-Aug |
Drug Metab. Dispos. |
pmid:7690698
|
Henke W and Jung K |
Comparison of the effects of the immunosuppressive agents FK 506 and cyclosporin A on rat kidney mitochondria. |
1993 |
Biochem. Pharmacol. |
pmid:7690566
|
Whitington PF et al. |
Orthotopic auxiliary liver transplantation for Crigler-Najjar syndrome type 1. |
1993 |
Lancet |
pmid:7690444
|
Olivera DL et al. |
Divergent effects of rapamycin on mouse and rat cells following mitogenic stimulation. |
1993 |
Clin. Immunol. Immunopathol. |
pmid:7690317
|
Hom JT and Estridge T |
FK506 and rapamycin modulate the functional activities of human peripheral blood eosinophils. |
1993 |
Clin. Immunol. Immunopathol. |
pmid:7690315
|
Cetinkale O et al. |
The use of FK506 and skin allografting for the treatment of severe burns in an animal model. |
1993 |
Br J Plast Surg |
pmid:7690295
|
Kobayashi J et al. |
A new rat infection-heart transplant model: effect of infection on graft survival studies. |
1993 Jul-Aug |
J. Heart Lung Transplant. |
pmid:7690253
|
Cheng JW et al. |
15N NMR relaxation studies of the FK506 binding protein: backbone dynamics of the uncomplexed receptor. |
1993 |
Biochemistry |
pmid:7690248
|
Jain AB et al. |
Pharmacokinetics of FK506 in liver transplant recipients after continuous intravenous infusion. |
1993 |
J Clin Pharmacol |
pmid:7690047
|
McMichael J et al. |
An intelligent and cost-effective computer dosing system for individualizing FK506 therapy in transplantation and autoimmune disorders. |
1993 |
J Clin Pharmacol |
pmid:7690046
|
Lieberman R |
FK506, artificial intelligence and pharmacoeconomics. |
1993 |
J Clin Pharmacol |
pmid:7690045
|
Tai PK et al. |
P59 (FK506 binding protein 59) interaction with heat shock proteins is highly conserved and may involve proteins other than steroid receptors. |
1993 |
Biochemistry |
pmid:7689858
|
Mollison KW et al. |
Comparison of FK-506, rapamycin, ascomycin, and cyclosporine in mouse models of host-versus-graft disease and heterotopic heart transplantation. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689812
|
Reem GH et al. |
FK-506 inhibits the IL-2-independent induction of the activation antigen CD 69. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689811
|
Starzl TE et al. |
Allograft and xenograft acceptance under FK-506 and other immunosuppressant treatment. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689809
|
Clardy J |
Structural studies of complexed FK-506 binding protein. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689808
|
Zenke G et al. |
Molecular mechanisms of immunosuppression by cyclosporins. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689806
|
Parsons WH et al. |
FK-506--a novel immunosuppressant. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689805
|
Kino T and Goto T |
Discovery of FK-506 and update. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689804
|
Christensen BG |
FK-506: its role in immunosuppression. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689803
|
Abu-Elmagd K et al. |
Resolution of severe pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK 506). |
1993 |
Ann. Intern. Med. |
pmid:7689802
|
Kondo T et al. |
[Antitumor sensitivity test, subrenal capsule assay using FK-506: preliminary report]. |
1993 |
Nihon Geka Gakkai Zasshi |
pmid:7689693
|
Namiki Y et al. |
Tautomeric phenomenon of a novel potent immunosuppressant (FK506) in solution. I. Isolation and structure determination of tautomeric compounds. |
1993 |
J. Antibiot. |
pmid:7689551
|
McManus BM et al. |
Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. |
1993 |
Clin. Immunol. Immunopathol. |
pmid:7689428
|
Fesik SW |
NMR structure-based drug design. |
1993 |
J. Biomol. NMR |
pmid:7689377
|
Ohzato H et al. |
Serum interleukin-6 levels as an indicator of acute rejection after liver transplantation in cynomologous monkeys. |
1993 |
Surg. Today |
pmid:7689373
|
Ueda D et al. |
Influence of FK 506 on renal blood flow. |
1993 |
Transplant. Proc. |
pmid:7689280
|
Dé P et al. |
Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3? |
1993 |
Transplant. Proc. |
pmid:7689279
|
Viebahn R et al. |
Simulation of hypoxic and preservation injury in human hepatocyte cultures: influence of FK 506 and cyclosporine. |
1993 |
Transplant. Proc. |
pmid:7689278
|
Winkler M et al. |
Plasma level-guided low-dose FK 506 therapy in patients with early liver dysfunction after liver transplantation. |
1993 |
Transplant. Proc. |
pmid:7689277
|
Jost U et al. |
FK 506 treatment of intractable rejection after liver transplantation. |
1993 |
Transplant. Proc. |
pmid:7689276
|
McMaster P and Buist L |
FK 506 in transplantation. |
1993 |
Transplant. Proc. |
pmid:7689275
|
Groth CG et al. |
New immunosuppressive drugs in transplantation. |
1993 |
Transplant. Proc. |
pmid:7689274
|
McCauley J et al. |
Renal transplantation under FK 506 in African-Americans: early experience. |
1993 |
Transplant. Proc. |
pmid:7689270
|
Odocha O et al. |
Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression. |
1993 |
Transplant. Proc. |
pmid:7689269
|
Odocha O et al. |
Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression. |
1993 |
Transplant. Proc. |
pmid:7689268
|
Valdivia LA et al. |
Dendritic cell replacement in long-surviving liver and cardiac xenografts. |
1993 |
Transplantation |
pmid:7689265
|
Shaefer MS et al. |
Falsely elevated FK-506 levels caused by sampling through central venous catheters. |
1993 |
Transplantation |
pmid:7689264
|
Taylor-Fishwick DA et al. |
Evidence that rapamycin has differential effects of IL-4 function. Multiple IL-4 signaling pathways and implications for in vivo use. |
1993 |
Transplantation |
pmid:7689258
|
Jin YJ and Burakoff SJ |
The 25-kDa FK506-binding protein is localized in the nucleus and associates with casein kinase II and nucleolin. |
1993 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7689229
|
Hoof T et al. |
Reversal of multidrug resistance in Chinese hamster ovary cells by the immunosuppressive agent rapamycin. |
1993 |
Eur. J. Pharmacol. |
pmid:7689059
|
Garrity GM et al. |
Genetic relationships among actinomycetes that produce the immunosuppressant macrolides FK506, FK520/FK523 and rapamycin. |
1993 |
J. Ind. Microbiol. |
pmid:7688970
|
Jacobs JC et al. |
Pyoderma gangrenosum in infancy. |
1993 |
J. Am. Acad. Dermatol. |
pmid:7688775
|
Smith DF et al. |
Two FKBP-related proteins are associated with progesterone receptor complexes. |
1993 |
J. Biol. Chem. |
pmid:7688746
|
Yamaoka K et al. |
Cyclosporin A and FK506 block the negative signaling mediated by surface IgM cross-linking in normal human mature B cells. |
1993 |
Immunol. Lett. |
pmid:7688712
|
Morkawa K et al. |
Immunosuppressive property of bromocriptine on human B lymphocyte function in vitro. |
1993 |
Clin. Exp. Immunol. |
pmid:7688676
|
Lyson T et al. |
Cyclosporine- and FK506-induced sympathetic activation correlates with calcineurin-mediated inhibition of T-cell signaling. |
1993 |
Circ. Res. |
pmid:7688670
|
Schmid FX |
Prolyl isomerase: enzymatic catalysis of slow protein-folding reactions. |
1993 |
Annu Rev Biophys Biomol Struct |
pmid:7688608
|
Machida M |
[Effect of temperature on plasma concentration of FK506]. |
1993 |
Nippon Hinyokika Gakkai Zasshi |
pmid:7688443
|
Pleyer U et al. |
Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye. |
1993 |
Invest. Ophthalmol. Vis. Sci. |
pmid:7688360
|
Ueki M et al. |
Diabetogenic effects of FK506 on renal subcapsular islet isografts in rat. |
1993 |
Diabetes Res. Clin. Pract. |
pmid:7688276
|
Entani C et al. |
Effect of a novel immunosuppressant, FK506, on spontaneous lupus nephritis in MRL/MpJ-lpr/lpr mice. |
1993 |
Nephron |
pmid:7688103
|
Hirakawa K et al. |
[The effect of perioperative portal venous inoculation with donor lymphocytes in combination with immunosuppressive agents on rat cardiac allograft survivals]. |
1993 |
Nihon Geka Gakkai Zasshi |
pmid:7688065
|
Heitman J et al. |
The immunosuppressant FK506 inhibits amino acid import in Saccharomyces cerevisiae. |
1993 |
Mol. Cell. Biol. |
pmid:7687745
|
Bram RJ et al. |
Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location. |
1993 |
Mol. Cell. Biol. |
pmid:7687744
|
Przepiorka D et al. |
Bronchiolitis obliterans organizing pneumonia in a BMT patient receiving FK506. |
1993 |
Bone Marrow Transplant. |
pmid:7687503
|
Altmeyer A and Dumont FJ |
Rapamycin inhibits IL-1-mediated interferon-gamma production in the YAC-1 T cell lymphoma. |
1993 |
Cytokine |
pmid:7687472
|
Denesyuk AI et al. |
Comparison of conformations of cyclosporin A and macrolide FK506 fragments: localization of putative binding sites with phosphatase calcineurin. |
1993 |
Biochem. Biophys. Res. Commun. |
pmid:7687433
|
Antoni FA et al. |
Inhibitory role for calcineurin in stimulus-secretion coupling revealed by FK506 and cyclosporin A in pituitary corticotrope tumor cells. |
1993 |
Biochem. Biophys. Res. Commun. |
pmid:7687429
|
Roelen DL et al. |
Differential inhibition of primed alloreactive CTLs in vitro by clinically used concentrations of cyclosporine and FK506. |
1993 |
Transplantation |
pmid:7687397
|
Iwata H et al. |
Suppression of allograft responses by combining donor alloantigen-specific intravenous presensitization with suboptimal doses of FK506. |
1993 |
Transplantation |
pmid:7687396
|
Warty V et al. |
FK506 measurement: comparison of different analytical methods. |
1993 |
Ther Drug Monit |
pmid:7687389
|
Nishizawa S et al. |
Therapeutic effect of a new immunosuppressant, FK-506, on vasospasm after subarachnoid hemorrhage. |
1993 |
Neurosurgery |
pmid:7687044
|
Nishi M et al. |
Effects of the immunosuppressant FK506 on a penetrating keratoplasty rejection model in the rat. |
1993 |
Invest. Ophthalmol. Vis. Sci. |
pmid:7686893
|
Koga T et al. |
Pulmonary infiltrates recovered by FK506 in a patient with Behçet's disease. |
1993 |
Chest |
pmid:7686837
|
Schreier MH |
Immunophilins and immunosuppression. |
1993 Mar-Apr |
Clin. Exp. Rheumatol. |
pmid:7686830
|